When understanding of these preliminary results gets out......we should see the share price rise to more historical levels... $0.37-$0.46.
It's kind of insane to see the world's best, least toxic, easiest and most economical cure for non-muscle invasive bladder cancer (NMIBC) treated so poorly by the markets, but it is what it is.
Meanwhile, reading today's posts, I kind of understand why the general public is underwhelmed. So many acronyms make your posts indecipherable to any but the regulars here.
Have a think about that, boys.
No point in saving yourselves a few seconds of typing, only to cause minutes of googling and clue-searching to figure out what you mean by the few motivated enough to try.
Oh, well, it is what it is.
GLTA!